Length of survival of patients with acquired immune deficiency syndrome in the United Kingdom

49Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

An analysis of the lengths of survival of patients with the acquired immune deficiency syndrome presenting with different opportunistic diseases was performed using epidemiological data routinely collected at the PHLS Communicable Disease Surveillance Centre. The overall crude case fatality rate was 55.4% (93/168). The median survival times were: 21.2 months for Kaposi's sarcoma, 12.5 months for Pneumocystis carinii pneumonia, and 13.3 months for other opportunistic infections. The shortest median survival time (6.6 months) was found for those with both Kaposi's sarcoma and P carinii pneumonia. There were significant differences between durations of survival of patients with Kaposi's sarcoma and those with all other diseases, which indicated impaired cellular immunity apart from opportunistic infections. This analysis shows that those with Kaposi's sarcoma alone have the most favourable prognosis. © 1986, British Medical Journal Publishing Group. All rights reserved.

Cite

CITATION STYLE

APA

Marasca, G., & McEvoy, M. (1986). Length of survival of patients with acquired immune deficiency syndrome in the United Kingdom. British Medical Journal (Clinical Research Ed.), 292(6537), 1727–1729. https://doi.org/10.1136/bmj.292.6537.1727

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free